Oncology Monoclonal Antibodies
5- Rituximab
- Trastuzumab
- Bevacizumab
- Cetuximab
- Pertuzumab
Speciality biological portfolio
Explore major biological-medicine groups used across oncology, autoimmune care, haematology, endocrinology and hospital practice. Biosimilar availability is molecule-, brand- and approval-specific.
Share the generic or product name, preferred brand, strength or specification, dosage form and required quantity. Current availability and quotation are confirmed individually.
Catalogue information is for professional B2B product-enquiry purposes only. It is not medical advice, a prescription, a stock statement or a guarantee of availability. Products are supplied subject to applicable regulations and suitable logistics.